NASDAQ:RENE Cartesian Growth Co. II (RENE) Stock Price, News & Analysis $11.97 +0.05 (+0.42%) As of 05/6/2025 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cartesian Growth Co. II Stock (NASDAQ:RENE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RENE alerts:Sign Up Key Stats Today's Range$11.93▼$11.9550-Day Range$11.69▼$11.9752-Week Range$11.21▼$11.95Volume4,006 shsAverage Volume87,831 shsMarket Capitalization$258.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY.Read More… Receive RENE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cartesian Growth Co. II and its competitors with MarketBeat's FREE daily newsletter. Email Address RENE Stock News HeadlinesCartesian Growth Corp II extends business combination periodMarch 5, 2025 | investing.comCartesian Growth Corp II extends business combination deadlineFebruary 5, 2025 | msn.comWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. May 7, 2025 | Altimetry (Ad)Positive Buy Rating for Cartesian Therapeutics Amid Encouraging Developments in Descartes-08 TrialsJanuary 28, 2025 | markets.businessinsider.comCartesian Growth Corporation IIDecember 23, 2024 | investing.comBertrand P. Grabowski's Net WorthNovember 2, 2024 | benzinga.comSee More Headlines RENE Stock Analysis - Frequently Asked Questions How have RENE shares performed this year? Cartesian Growth Co. II's stock was trading at $11.66 on January 1st, 2025. Since then, RENE shares have increased by 2.7% and is now trading at $11.97. View the best growth stocks for 2025 here. How do I buy shares of Cartesian Growth Co. II? Shares of RENE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cartesian Growth Co. II own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cartesian Growth Co. II investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Bank of America (BAC). Company Calendar Today5/06/2025Next Earnings (Estimated)5/21/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry Holding & other investment offices Sub-IndustryTrading Current SymbolNASDAQ:RENE CIK1889112 Webwww.cartesiangrowth.com Phone212-461-6363FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$11.44 million Net MarginsN/A Pretax MarginN/A Return on Equity-51.08% Return on Assets5.43% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.09 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.41 per share Price / Cash Flow29.45 Book Value($0.64) per share Price / Book-18.70Miscellaneous Outstanding Shares21,621,000Free Float15,870,000Market Cap$258.80 million OptionableNot Optionable Beta-0.01 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:RENE) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Growth Co. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Growth Co. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.